AMD 101

Over the past 15 years, tremendous advances have been made in the detection and treatment of age-related macular degeneration AMD. Numerous peer-reviewed scientific papers are published every month, covering a broad range of topics ranging from epidemiology to treatment. Although the expanded knowledge is welcome news, the information overload has made it difficult for clinicians to keep up with the science, much less understand the implications for patient care. This program will address this need by outlining practical, evidence-based strategies that can be implemented in a medically-oriented practice.

Seminar Information
Seminar Date:
June 27, 2020
Seminar Objectives
  • 1. The attendee, at the conclusion of this course, should recognize the significant under diagnosis of early AMD
  • 2. The attendee, at the conclusion of this course, should recognize means for early diagnosis of subclinical AMD
  • 3. The attendee should recognize the important interventional role that optometrists can play when subclinical AMD is diagnosed.
AMD 101
Speaker Information
Leo Semes
ProductAddPrice
On-Demand
AOA Price:$0.00
Individual topic purchase: Selected
American Optometric Association
AOA Approved: 1.00
Products
On-Demand
AOA Price:$0.00